With sotro­vimab in the bal­ance, Bio­gen vet re­unites with George Scan­gos at Vir; First woman to chair PhRMA has more in store at Take­da

Vir Biotech­nol­o­gy is get­ting an­oth­er Bio­gen vet to join up as the start­up’s new glob­al CBO and EVP.

While Jo­han­na Friedl-Nader­er of­fi­cial­ly doesn’t start her first C-suite role for an­oth­er few weeks on March 2, she will join the com­pa­ny in the midst of con­flict­ing da­ta re­gard­ing its Glax­o­SmithK­line-part­nered Covid-19 an­ti­body, and armed with decades of work­ing at the re­cent­ly-em­broiled Bio­gen.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER